🔎 Trials Near Me

Beranda › Kanker Ginjal (Karsinoma Sel Renal) › Alabama

Uji klinis Kanker Ginjal (Karsinoma Sel Renal) di Alabama

7 studi untuk Kanker Ginjal (Karsinoma Sel Renal) mencari peserta di lokasi di Alabama.

Kota di Alabama

Teks studi resmi (Bahasa Inggris)

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

  • Research Site, Birmingham
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT05536141

DESTINY-PANTUMOUR04

  • Research Site, Birmingham
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • University of Alabama at Birmingham, Birmingham
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05059444

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

  • University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Mei 2026 · NCT05363280

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • University of Alabama at Birmingham, Birmingham
  • University of South Alabama, Mobile
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT05297734

Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)

  • University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Okt 2025 · NCT06005818

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

  • University of Alabama at Birmingham Cancer Center, Birmingham
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2025 · NCT04510597

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.